期刊文献+

多柔比星对乳腺癌细胞核内丝切蛋白相互作用蛋白影响的比较蛋白质组学研究 被引量:3

Effects of doxorubicin on cofilin interacting proteins in nucleus of breast cancer cells through comparative proteomics
下载PDF
导出
摘要 目的采用比较蛋白质组学的方法,检测多柔比星对乳腺癌细胞核内丝切蛋白(cofilin)相互作用蛋白的影响。方法采用Western blot检测多柔比星对细胞核内cofilin表达的影响;免疫共沉淀后,采用比较蛋白质组学方法,检测对照组与多柔比星处理组细胞核内cofilin相互作用蛋白的差异;采用流式细胞仪检测多柔比星对细胞周期的影响。结果多柔比星处理MDA-MB-231细胞后,细胞核内cofilin表达增加,呈明显量效和时效关系;与对照组比较,多柔比星处理组核内与cofilin相互作用的蛋白结合蛋白、结构分子激活蛋白、细胞骨架蛋白、核酸结合蛋白、核糖体蛋白的种类明显减少(109、60、45、76、34 vs 79、32、20、56、16);多柔比星处理细胞后,可引起细胞周期阻滞在S/G2期,并呈明显量效关系,G1期细胞由(45.92±4.57)%降至(10.50±0.83)%(P<0.01)。结论多柔比星处理细胞后可增加cofilin核聚集,减少细胞核内与cofilin相互作用蛋白的种类,最终使细胞周期阻滞在S/G2期。 Objective To determine the effects of doxorubicin on cofilin interacting proteins in the nucleus of breast cancer cells. Methods The expression of cofilin in the nucleus was evaluated by Western blotting. After immunoprecipitation,the differences of cofilin interacting proteins in the nucleus between the controls and doxorubicin-treated cells were determined by comparative proteomics. The effects of doxorubicin on cell cycle were determined by flow cytometry. Results Doxorubicin treatment resulted in an increase of cofilin level in the nucleus of MDA-MB-231 cells in dose-and time-dependent manner. Compared with the controls,doxorubicin treatment also resulted in a decreases of the types of cofilin interacting proteins including protein binding proteins,structural molecule activity proteins,cytoskeleton proteins,nucleic acid binding proteins,and ribosome proteins( 109,60,45,76,and 34 vs 79,32,20,56,and 16,respectively).Furthermore,doxorubicin treatment led to cell cycle arrest at S/G2 phase in a dose-dependent manner and the percentage of cells at G1 phase was declined from( 45. 92 ± 4. 57) % to( 10. 50 ± 0. 83) %( P〈0. 01).Conclusion Doxorubicin treatment increases the accumulation of cofilin in the nuclear,decreases the types of cofilin interacting proteins,and finally leads to cell cycle arrest at S/G2 phase.
作者 刘艳霞 李雨浓 傅若秋 高宁 Liu Yanxia Li Yunong Fu Ruoqiu Gao Ning(Department of Pharmacognosy and Natural Pharmaceutical Chemistry, College of Pharmacy, Third Military Medical University, Chongqing, 400038, Chin)
出处 《第三军医大学学报》 CAS CSCD 北大核心 2017年第6期522-528,共7页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(31571425)~~
关键词 多柔比星 乳腺癌 丝切蛋白 细胞核 比较蛋白质组学 doxorubicin breast cancer cofilin nucleus comparative proteomics
  • 相关文献

参考文献3

二级参考文献25

  • 1MA X T.The research progress of signal transducers and activators of transcription 3 and the tumor drug resistance [J].Cancer Res Prev Treat,2011,38(4):474-475.
  • 2ZHAO M,JIANG B,GAO F H.Small molecule inhibitors of STAT3 for cancer therapy [J].Curr Med Chem,2011,18(26):4012-4018.
  • 3ZHANG X L,ZHANG J,ZHANG C,et al.Experimental therapy of tumor by blockade of transcription factor Stat3 activation via induction of apoptosis and reversing of multidrug resistance [C].Xi′an:The 6th Congress of the Chinese Society of Immunology,2008:138-139.
  • 4LIU A,LIU Y,JIN Z,et al.XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancreatic cancer cells [J].PLoS One,2012,7 (10):e46624.
  • 5ZHOU J,ONG C N,HUR G M,et al.Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin [J].Biochem Pharmacol,2010,79 (9):1242-1250.
  • 6FALAMARZIAN A,ALIABADI H M,MOLAVI O,et al.Effective down-regualtion of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy [J].J Biomed Mater Res A,2014,102 (9):3216-3218.
  • 7GARIBOLDI M B,RAVIZZA R,MOLTENI R,et al.Inhibition of STAT3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line [J].Cancer Lett,2007,258(2):181-188.
  • 8SIEGEL R,NAISHADHAM D,JEMAL A,et al.Cancer statistics,2012 [J].CA Cancer J Clin,2012,62(1):10-29.
  • 9LACERDA L,PUSZTAI L,WOODWARD W A,et al.The role of tumor initiating cells in drug resistance of breast cancer:implication for future therapeutic approaches [J].Drug Resist Updat,2010,13(4-5):99-108.
  • 10YUQI G,JEFFREY N,COLIN O,et al.Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer [J].Clin Cancer Res,2010,16(23):5759-5769.

共引文献24

同被引文献37

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部